Long-term survival of patients treated with BCNU for brain tumors

View More View Less
  • 1 Department of Neurological Surgery, University of California School of Medicine, San Francisco, California
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $515.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $612.00
Print or Print + Online

✓The authors present three patients who, after excision and irradiation of their brain tumors, were treated with BCNU for recurrence. All three patients responded well and now are without evidence of tumor, 37, 30, and 36 months after BCNU was stopped. Although these patients represent only a small fraction of those treated with BCNU, they indicate the potential role of chemotherapy in the management of glial tumors.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $515.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $612.00
  • 1.

    DeVita VT: Cell kinetics and the chemotherapy of cancer. Cancer Chemother Rep 2:2333, 1971 DeVita VT: Cell kinetics and the chemotherapy of cancer. Cancer Chemother Rep 2:23–33, 1971

    • Search Google Scholar
    • Export Citation
  • 2.

    Fokes EC Jr, & Earle KM: Ependymomas: clinical and pathological aspects. J Neurosurg 30:584594, 1969 Fokes EC Jr, Earle KM: Ependymomas: clinical and pathological aspects. J Neurosurg 30:584–594, 1969

    • Search Google Scholar
    • Export Citation
  • 3.

    Jelsma R, & Bucy P: Glioblastoma multiforme: its treatment and some factors affecting survival. Arch Neurol 20:161171, 1969 Jelsma R, Bucy P: Glioblastoma multiforme: its treatment and some factors affecting survival. Arch Neurol 20:161–171, 1969

    • Search Google Scholar
    • Export Citation
  • 4.

    Jelsma R, & Bucy P: The treatment of glioblastoma multiforme of the brain. J Neurosurg 27:388400, 1967 Jelsma R, Bucy P: The treatment of glioblastoma multiforme of the brain. J Neurosurg 27:388–400, 1967

    • Search Google Scholar
    • Export Citation
  • 5.

    Mabon RF, , Svien HJ, & Kernohan JW, et al: Ependymomas. Mayo Clin Proc 24:6571, 1949 Mabon RF, Svien HJ, Kernohan JW, et al: Ependymomas. Mayo Clin Proc 24:65–71, 1949

    • Search Google Scholar
    • Export Citation
  • 6.

    Svien HJ, , Mabon RF, & Kernohan JW, et al: Astrocytomas. Mayo Clin Proc 24:5464, 1949 Svien HJ, Mabon RF, Kernohan JW, et al: Astrocytomas. Mayo Clin Proc 24:54–64, 1949

    • Search Google Scholar
    • Export Citation
  • 7.

    Walker MD, & Gehan EA: An evaluation of 1,3 bis (2-chloroethyl)-l-nitrosourea (BCNU) and irradiation alone and in combination for the treatment of malignant glioma. Proc Am Assoc Cancer Res 13:267, 1972 Walker MD, Gehan EA: An evaluation of 1,3 bis (2-chloroethyl)-l-nitrosourea (BCNU) and irradiation alone and in combination for the treatment of malignant glioma. Proc Am Assoc Cancer Res 13:267, 1972

    • Search Google Scholar
    • Export Citation
  • 8.

    Walker MD, & Hurwitz BS: BCNU (1,3 bis (2-chloroethyl)-l-nitrosourea; NSC-409962) in the treatment of malignant brain tumor. A preliminary report. Cancer Chemother Rep 54:263271, 1970 Walker MD, Hurwitz BS: BCNU (1,3 bis (2-chloroethyl)-l-nitrosourea; NSC-409962) in the treatment of malignant brain tumor. A preliminary report. Cancer Chemother Rep 54:263–271, 1970

    • Search Google Scholar
    • Export Citation
  • 9.

    Wilson CB, , Boldrey EB, & Enot KJ: 1,3 bis (2-chloroethyl)-l-nitrosourea (NSC-409962) in the treatment of brain tumors. Cancer Chemother Rep 54:273281, 1970 Wilson CB, Boldrey EB, Enot KJ: 1,3 bis (2-chloroethyl)-l-nitrosourea (NSC-409962) in the treatment of brain tumors. Cancer Chemother Rep 54:273–281, 1970

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 216 50 1
Full Text Views 231 0 0
PDF Downloads 75 0 0
EPUB Downloads 0 0 0